Clinical Trials Browser

Terminated × OTHER × eltrombopag × Clear all

Leukemia

NCT02446145 2024-03-29

DELTA

Phase 2 Terminated

132 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Terminated

10 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01113502 2021-08-05

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

44 enrolled 16 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01656252 2020-11-03

PrE0901

Phase 1/2 Terminated

15 enrolled 5 charts

Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT02010645 2020-01-02

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

6 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Chronic

NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Phase 2 Terminated

1 enrolled 1 chart

Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

NCT01500538 2016-02-15

VEIL

Phase 2 Terminated

1 enrolled

Classical hematologyLymphoid

Lymphoma, Lymphoma, Follicular, Thrombocytopenia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01397149 2015-05-28

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Phase 1/2 Terminated

4 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Phase 1 Terminated

1 enrolled

Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Clinical Trials

REGALIA

DELTA

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

PrE0901

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

VEIL

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia